Berlin Heart AG Company Profile

08:09 EST 24th November 2017 | BioPortfolio

Berlin - a city with a heart for new scientific developments, the birthplace of German VAD (ventricular assist device) technology. Without doubt, one of the pioneering achievements in this city was a large-scale research project "Devices for artificial assistance and substitution of the human heart", which was launched 30 years ago at the Freie Universität Berlin.

Ever since the successful introduction of the extracorporeal VAD Berlin Heart EXCOR almost 15 years ago, we have been continuously working to improve this system. In many hundreds of applications, it has already proved its worth the world over.

In close co-operation with the German Heart Institute Berlin (DHZB - Deutsches Herzzentrum Berlin), we have been developing implantable heart support systems as well as the Excor mobile driving unit for the extracorporeal VAD system Berlin Heart EXCOR.

We are the VAD Specialists.


Wiesenweg 10


Phone: +49-(0)30-8187-2600
Fax: +49-(0)30-8187-2601

News Articles [1366 Associated News Articles listed on BioPortfolio]

Infographic: The Berlin Biotech Ecosystem

Together with Berlin Partner for Business and Technology, we have created an absolutely amazing infographic full of cool & fun facts about the Berlin Biotech Ecosystem. Click on the image below to...

Microsoft startet Newsroom in Berlin

BERLIN (dpa-AFX) - Microsoft hat einen internationalen Newsroom mit 70 Mitarbeitern in Berlin eröffnet. Dort werden seit Montag die Nachrichtenangebote auf MSN, der Suchmaschine Bing oder dem neue...

Infographic: Off to BIO-Europe 2017? Get ready for Berlin!

Are you ready to be presented with an awesome array of Berlin Biotech Information, just enough to get you ready and excited for BIO-Europe? What’s more, together with Berlin Partner for Business and...

Air Berlin scraps more flights as pilots call in sick

Insolvent Air Berlin cancelled dozens more flights Wednesday as pilots again called in sick, despite warnings from the airline that the wildcat action could jeopardise rescue talks. The mass "sick-ou...

Chinese tourists detained in Berlin for Hitler salute

Two Chinese tourists were detained in Berlin for making the straight-armed Hitler salute for photos in front of the Reichstag parliament building, a police spokeswoman said on Sunday. The holidaymake...

Heart break could lead to severe and long term heart damage

Heart break is actually damaging for the heart finds a new study. Researchers have found that persons undergoing a heart break could suffer from damages to the heart that is similar to heart attacks.

Berlin Institute of Health Partners with Startupbootcamp Digital Health

The Berlin Institute of Health (BIH) has partnered with Startupbootcamp Digital Health to collaborate on its startup accelerator program in Berlin. Startupbootcamp, a global network of industry-focuse...

HAEMATO-Aktie: Unerwarteter Umsatzrückgang in H1 - Kursziel reduziert! Aktienanalyse

Berlin - HAEMATO-Aktienanalyse von Aktienanalyst Ellis Acklin von First Berlin: Ellis Acklin, Aktienanalyst von First Berlin, bestätigt in einer aktuellen Aktienanalyse seine Kaufempfehlung für die....

PubMed Articles [2112 Associated PubMed Articles listed on BioPortfolio]

Ventricular assist device in a failing total cavopulmonary connection: a new step-by-step approach.

The management of failing Fontan patients with mechanical circulatory support has been reported with unsatisfactory results. A 5-year-old girl, listed for heart transplantation for failing Fontan, und...

The promise of stromal cell-derived factor-1 in novel heart disease treatments.

Fluid overload independent of acute kidney injury predicts poor outcomes in neonates following congenital heart surgery.

Fluid overload (FO) is common after neonatal congenital heart surgery and may contribute to mortality and morbidity. It is unclear if the effects of FO are independent of acute kidney injury (AKI).

Accuracy of Berlin questionnaire with different body mass index cutoff values in the screening of patients with obstructive sleep apnea.

Objective: To evaluate the accuracy of Berlin questionnaire in the screening of patients with obstructive sleep apnea (OSA), after using different body mass index (BMI) cutoff values. Methods: The dat...

Contemporary Approaches to Patients with Heart Failure.

Incident heart failure and the burden of hospitalization may be demonstrating a decline. However, as the population ages, the prevalence of heart failure continues to increase. Mortality among heart f...

Clinical Trials [3357 Associated Clinical Trials listed on BioPortfolio]

EXCOR Pediatric Ventricular Assist Device (VAD)

The purpose of the study is to determine whether use of the Berlin Heart EXCOR Pediatric VAD for bridge-to-transplant is associated with a reasonable assurance of safety and probable benef...

Sleep Apnea Screening

To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator (ICD) or...

Preventive aBlation of vEntricular tachycaRdia in Patients With myocardiaL INfarction

The BERLIN VT study is designed to evaluate the impact of prophylactic ventricular tachycardia (VT) ablation on all-cause mortality and unplanned hospital admission for congestive heart fa...

Stratification of the Acute Respiratory Distress Syndrome

The American-European Consensus Conference (AECC) and the Berlin definitions of the Acute Respiratory Distress Syndrome (ARDS) could be adequate for epidemiologic studies, but it is not ad...

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Efficacy of BC 007 in Healthy Subjects

Berlin Cures develops BC 007 to treat patients suffering from diseases (chronic heart failure, pulmonary hypertension, chronic fatigue syndrome etc.) which are associated with functional a...

Companies [768 Associated Companies listed on BioPortfolio]

Berlin Heart AG

Berlin - a city with a heart for new scientific developments, the birthplace of German VAD (ventricular assist device) technology. Without doubt, one of the pioneering achievements in this city was a ...

Berlin Heart,Inc

In 1997 the acquisition of the paracoporeal device with the name"Berlin Heart" from the company Fehling Medical AG took place the Mediport Berlin Heart Gmbh Kardiotechnik Was Founded.In order to make ...

Berlin Heart GmbH

Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The company is...

Berlin Partner GmbH

Berlin Partner, the official economic development agency for the city of Berlin, Germany, partners with companies, providing one-stop service and support for companies considering...


BERLIN-CHEMIE develops, produces and markets pharmaceutical products. BERLIN-CHEMIE AG is part of the global MENARINI GROUP, which is headquartered in Florence/Italy. MENARINI is the largest Italian p...

More Information about "Berlin Heart AG" on BioPortfolio

We have published hundreds of Berlin Heart AG news stories on BioPortfolio along with dozens of Berlin Heart AG Clinical Trials and PubMed Articles about Berlin Heart AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Berlin Heart AG Companies in our database. You can also find out about relevant Berlin Heart AG Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record